Impact of new oral or intravenous P2Y12 inhibitors and clopidogrel on major ischemic and bleeding events in patients with coronary artery disease: A meta-analysis of randomized trials-Reference-Cited by-同舟云学术

Impact of new oral or intravenous P2Y12 inhibitors and clopidogrel on major ischemic and bleeding events in patients with coronary artery disease: A meta-analysis of randomized trials

Published:2014-04 Issue:2 Volume:233 Page:568-578
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Tang Xiao-Fang,Fan Jing-Yao,Meng Jing,Jin Chen,Yuan Jin-Qing,Yang Yue-Jin

Funder

Twelfth Five-Year Plan of Republic of China

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference44 articles.

1. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without st-segment elevation;Yusuf;N Engl J Med,2001

2. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial;Steinhubl;J Am Med Assoc,2002

3. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with st-segment elevation;Sabatine;N Engl J Med,2005

4. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial;Chen;Lancet,2005

5. Variability in platelet responsiveness to clopidogrel among 544 individuals;Serebruany;J Am Coll Cardiol,2005

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of ischaemic and haemorrhagic stroke in Chinese undergoing percutaneous coronary intervention treated with potent P2Y12 inhibitor versus clopidogrel;Stroke and Vascular Neurology;2022-03-09

2. The Molecular Aspects of Disturbed Platelet Activation Through ADP/P2Y12 Pathway in Multiple Sclerosis;International Journal of Molecular Sciences;2021-06-18

3. Efficacy and safety of newer P2Y12 inhibitors for acute coronary syndrome: a network meta-analysis;Scientific Reports;2020-10-08

4. Antithrombotic Treatments in Patients with Chronic Coronary Artery Disease or Peripheral Artery Disease: A Systematic Review of Randomised Controlled Trials;Cardiovascular Therapeutics;2020-06-30

5. Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis;BMC Cardiovascular Disorders;2020-03-12